Ilyang Pharmaceutical Co.,Ltd

KOSE:A007575 Stock Report

Market Cap: ₩199.2b

Ilyang PharmaceuticalLtd Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Dong-Yeon Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.05%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Dong-Yeon Kim (74 yo)

no data

Tenure

Mr. Dong-Yeon Kim serves as the Chief Executive Officer and President of Ilyang Pharmaceutical Co., Ltd. Mr. Kim served as Head of Laboratory at Ilyang Pharmaceutical Co., Ltd. He serves as a Director of I...